Skip to main content

UFP Technologies, Inc. (UFPT) Stock Analysis

Range Bound setup

Buy WaitModerate Confidence

Healthcare · Medical Devices

Earnings in 3 days (2026-05-04). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $188.22. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $194.92. Engine's entry $188.22 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum.

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort,... Read more

$194.92+46.5% A.UpsideScore 4.8/10#35 of 40 Medical Devices
Entry $188.22(support + ATR)Stop $178.15Target $275.82(analyst − 15%)A.R:R 4.5:1Setup A.R:R 8.6:1
Analyst target$324.50+66.5%2 analysts
$275.82our TP
$194.92price
$324.50mean
$360

Wait for pullback to $188.22. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $194.92. Engine's entry $188.22 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: RSI 42 mid-range, Bollinger mid-band. Earnings in 3 days. Wait until post-earnings. Score 4.8/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 3d<=7d. Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
No bear case signals

Key Metrics

P/E (TTM)21.9
P/E (Fwd)16.7
Mkt Cap$1.5B
EV/EBITDA14.4
Profit Mgn11.3%
ROE17.8%
Rev Growth3.4%
Beta1.17
DividendNone
Rating analysts10

Quality Signals

Piotroski F8/9

Options Flow

P/C3.00bearish
IV78%elevated
Max Pain$155-20.5% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
1.0
Volume
1.1
Macd
1.6
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope -3.1%/30d — confirmed downtrend

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.4
Earnings Growth
3.4

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
2.5
Value Rank
5.8
Quality Rank
6.8
GatesMomentum 1.8<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 3d<=7dA.R:R 4.5 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
42 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $183.66Resistance $207.60

Price Targets

$178
$188
$276
A.Upside+41.5%
A.R:R4.5:1
Setup A.R:R (at entry)8.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Earnings in 3 days - binary event risk
! Momentum score 1.8/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-04 (3d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UFPT stock a buy right now?

Wait for pullback to $188.22. Weak momentum; also below 200-day MA (death cross) — blocks BUY_NOW at $194.92. Engine's entry $188.22 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: RSI 42 mid-range, Bollinger mid-band. Earnings in 3 days. Wait until post-earnings. Target $275.82 (+41.5%), stop $178.15 (−9.4%), Setup A.R:R 8.6:1. Score 4.8/10, moderate confidence.

What is the UFPT stock price target?

Take-profit target: $275.82 (+46.5% upside). Target $275.82 (+41.5%), stop $178.15 (−9.4%), Setup A.R:R 8.6:1. Stop-loss: $178.15.

Is UFPT overvalued or undervalued?

UFP Technologies, Inc. trades at a P/E of 21.9 (forward 16.7). TrendMatrix value score: 5.8/10. Verdict: Buy (Wait for Entry).

What do analysts say about UFPT?

10 analysts cover UFPT with a consensus score of 3.9/5. Average price target: $325.

What does UFP Technologies, Inc. do?UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile...

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Related stocks: GMED (Globus Medical, Inc.) · TMDX (TransMedics Group, Inc.) · INSP (Inspire Medical Systems, Inc.) · HAE (Haemonetics Corporation) · AXGN (AxoGen, Inc.)